NCT04062851

Brief Summary

The practice of checking gastric residuals is not evidence based. The amount of gastric residual volume (GRV) does not correlate with either feeding intolerance or development of NEC. We hypothesize that not monitoring GRV in infants with birth weights \< 1,250 g, and who are being fed intermittently by gastric tube, will result in earlier attainment of full feeding. This is an unblinded randomized controlled trial where GRV will not be checked routinely in the intervention group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2019

Completed
24 days until next milestone

Study Start

First participant enrolled

May 3, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

August 20, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 26, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

April 26, 2022

Status Verified

April 1, 2022

Enrollment Period

2.2 years

First QC Date

April 9, 2019

Last Update Submit

April 22, 2022

Conditions

Keywords

gastric residuals, feeding, very low birth weight infants

Outcome Measures

Primary Outcomes (1)

  • Days to reach full enteral feeds

    Days to reach enteral feeding volume of 120ml/kg/day

    1 month after enrollment

Secondary Outcomes (3)

  • Necrotizing enterocolitis

    Until hospital discharge, an average of 2-6 months

  • weight gain

    4 weeks chronological age and 36 weeks corrected gestation

  • frequency of feeding interruptions

    Until full feeds are reached, usually between 2 weeks - 2 months

Study Arms (2)

GRV group

NO INTERVENTION

Gastric residuals will be checked prior to feeds

NO GRV group

EXPERIMENTAL

Gastric residuals will not be checked prior to feeds

Other: No Gastric residual volume monitoring

Interventions

Gastric residual volumes will not be monitored

NO GRV group

Eligibility Criteria

Age2 Hours - 1 Month
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Birth weight ≤1250g
  • Gestational age of \< 33 weeks
  • Expected to receive feeds via gastric tubes

You may not qualify if:

  • Death expected within 72 hours of birth
  • Major chromosomal or congenital anomaly
  • Major GI anomaly such as gastroschisis, spontaneous perforation etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AdventHealth

Orlando, Florida, 32803, United States

Location

Related Publications (3)

  • Li YF, Lin HC, Torrazza RM, Parker L, Talaga E, Neu J. Gastric residual evaluation in preterm neonates: a useful monitoring technique or a hindrance? Pediatr Neonatol. 2014 Oct;55(5):335-40. doi: 10.1016/j.pedneo.2014.02.008. Epub 2014 Aug 14.

  • Torrazza RM, Parker LA, Li Y, Talaga E, Shuster J, Neu J. The value of routine evaluation of gastric residuals in very low birth weight infants. J Perinatol. 2015 Jan;35(1):57-60. doi: 10.1038/jp.2014.147. Epub 2014 Aug 28.

  • Parker L, Torrazza RM, Li Y, Talaga E, Shuster J, Neu J. Aspiration and evaluation of gastric residuals in the neonatal intensive care unit: state of the science. J Perinat Neonatal Nurs. 2015 Jan-Mar;29(1):51-9; quiz E2. doi: 10.1097/JPN.0000000000000080.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Narendra Dereddy, MD

    AdventHealth

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Unblinded Single center Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2019

First Posted

August 20, 2019

Study Start

May 3, 2019

Primary Completion

July 26, 2021

Study Completion

March 31, 2022

Last Updated

April 26, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations